LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.64 | 17.25 | 1180 | 1887 | 0.6252 | 0.8660 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 30.64 | 17.25 | 1539 | 1887 | 0.8154 | 0.9406 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.61 | 17.25 | 11 | 2136 | 0.0051 | -0.0627 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.61 | 17.25 | 1422 | 2136 | 0.6656 | 0.8863 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.61 | 17.25 | 1218 | 2136 | 0.5701 | 0.8447 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 32.61 | 17.25 | 1631 | 2136 | 0.7635 | 0.9238 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.57 | 17.25 | 6 | 2523 | 0.0024 | -0.1366 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.57 | 17.25 | 1504 | 2523 | 0.5961 | 0.8612 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.57 | 17.25 | 1520 | 2523 | 0.6024 | 0.8639 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 34.57 | 17.25 | 1753 | 2523 | 0.6948 | 0.9013 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.54 | 17.25 | 8 | 2679 | 0.0030 | -0.1002 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.54 | 17.25 | 1656 | 2679 | 0.6180 | 0.8720 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.54 | 17.25 | 1620 | 2679 | 0.6045 | 0.8664 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.54 | 17.25 | 1863 | 2679 | 0.6952 | 0.9026 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.51 | 17.25 | 14 | 2906 | 0.0048 | -0.0278 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.51 | 17.25 | 1777 | 2906 | 0.6115 | 0.8713 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.51 | 17.25 | 1727 | 2906 | 0.5943 | 0.8641 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.51 | 17.25 | 1973 | 2906 | 0.6789 | 0.8980 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.48 | 17.25 | 15 | 3125 | 0.0048 | -0.0185 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.48 | 17.25 | 1877 | 3125 | 0.6005 | 0.8685 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.48 | 17.25 | 1891 | 3125 | 0.6050 | 0.8704 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.48 | 17.25 | 2151 | 3125 | 0.6882 | 0.9028 | MN20160310_N02 | F04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.45 | 17.25 | 336 | 3504 | 0.0959 | 0.4730 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.45 | 17.25 | 2048 | 3504 | 0.5845 | 0.8647 | MN20160310_N02 | C22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.45 | 17.25 | 1765 | 3504 | 0.5037 | 0.8289 | MN20160310_N02 | F04 |